Gill J - Search Results

1

The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.

Gill J, Connolly P, Roth M, Chung SH, Zhang W, Piperdi S, Hoang B, Yang R, Guzik H, Morris J, Gorlick R, Geller DS. Gill J, et al. PLoS One. 2017 Mar 6;12(3):e0173322. doi: 10.1371/journal.pone.0173322. eCollection 2017. PLoS One. 2017. PMID: 28264040 Free PMC article.

2

New targets and approaches in osteosarcoma.

Gill J, Ahluwalia MK, Geller D, Gorlick R. Gill J, et al. Pharmacol Ther. 2013 Jan;137(1):89-99. doi: 10.1016/j.pharmthera.2012.09.003. Epub 2012 Sep 14. Pharmacol Ther. 2013. PMID: 22983152 Review.

3

β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells.

Piperdi S, Austin-Page L, Geller D, Ahluwalia M, Gorlick S, Gill J, Park A, Zhang W, Li N, Chung SH, Gorlick R. Piperdi S, et al. Among authors: gill j. Sarcoma. 2012;2012:164803. doi: 10.1155/2012/164803. Epub 2012 Oct 18. Sarcoma. 2012. PMID: 23125530 Free PMC article.

4

Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma.

Roth M, Linkowski M, Tarim J, Piperdi S, Sowers R, Geller D, Gill J, Gorlick R. Roth M, et al. Among authors: gill j. Cancer. 2014 Feb 15;120(4):548-54. doi: 10.1002/cncr.28461. Epub 2013 Oct 25. Cancer. 2014. PMID: 24166473 Free PMC article.

5

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.

Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N. Gorlick S, et al. Among authors: gill j. Pediatr Blood Cancer. 2014 Sep;61(9):1558-64. doi: 10.1002/pbc.25074. Epub 2014 Apr 22. Pediatr Blood Cancer. 2014. PMID: 24753182 Free PMC article.

6

HER-2 involvement in osteosarcoma.

Gill J, Geller D, Gorlick R. Gill J, et al. Adv Exp Med Biol. 2014;804:161-77. doi: 10.1007/978-3-319-04843-7_9. Adv Exp Med Biol. 2014. PMID: 24924174 Review.

7

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.

Cao Y, Roth M, Piperdi S, Montoya K, Sowers R, Rao P, Geller D, Houghton P, Kolb EA, Gill J, Gorlick R. Cao Y, et al. Among authors: gill j. PLoS One. 2014 Aug 29;9(8):e106249. doi: 10.1371/journal.pone.0106249. eCollection 2014. PLoS One. 2014. PMID: 25170759 Free PMC article.

8

Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2.

Geller DS, Singh MY, Zhang W, Gill J, Roth ME, Kim MY, Xie X, Singh CK, Dorfman HD, Villanueva-Siles E, Park A, Piperdi S, Gorlick R. Geller DS, et al. Among authors: gill j. Clin Cancer Res. 2015 Jul 1;21(13):3003-12. doi: 10.1158/1078-0432.CCR-14-0986. Epub 2014 Dec 3. Clin Cancer Res. 2015. PMID: 25472999

9

Variability in the reported management of pulmonary metastases in osteosarcoma.

Bhattasali O, Vo AT, Roth M, Geller D, Randall RL, Gorlick R, Gill J. Bhattasali O, et al. Among authors: gill j. Cancer Med. 2015 Apr;4(4):523-31. doi: 10.1002/cam4.407. Epub 2015 Jan 28. Cancer Med. 2015. PMID: 25626877 Free PMC article.

10

Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma.

Poon VI, Roth M, Piperdi S, Geller D, Gill J, Rudzinski ER, Hawkins DS, Gorlick R. Poon VI, et al. Among authors: gill j. Clin Sarcoma Res. 2015 Jan 24;5(1):4. doi: 10.1186/s13569-014-0020-9. eCollection 2015. Clin Sarcoma Res. 2015. PMID: 25642322 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,341 results

Search Page

Filters